Issue 4 Volume 17 (2026)

Gastritis and mucosal erosions are common clinical challenges in veterinary medicine. While conventional treatments manage acidity, there is a growing demand for nutraceuticals that directly address gastric inflammation. This study investigated the anti-inflammatory potential of the multi-component formulation, using an in vitromodel of human gastric epithelial cells (AGS). Cell viability was first assessed via MTT assay to identify non-cytotoxic dosages. Subsequently, AGS cells were challenged

---

Read More

Gene essentiality is often summarized as whether disruption of a gene reduces cellular or organismal fitness, yet functional-genomic evidence shows that this phenotype depends on the perturbation applied, the biological background in which it is imposed, the compensatory capacity of the system, and the environment in which fitness is measured. This article develops a causal account for interpreting context-dependent essentiality without treating screen-derived dependency scores as intrinsic, con

---

Read More

Durability has become a central descriptor of somatic gene-therapy performance, yet the term is frequently applied to biologically different observations. Persistent vector DNA, continued transgene expression, long-lived corrected cells, and sustained therapeutic function can coincide, but none is an automatic surrogate for the others. This conceptual framework separates these layers and examines the biological and measurement conditions under which each can support a claim of durable therapeuti

---

Read More

A cellular phenotype rarely identifies its molecular cause uniquely. Regulatory redundancy, resource competition, compensatory interactions, alternative network configurations, and incomplete measurement can allow distinct molecular states to generate observations that are difficult or impossible to distinguish under a given assay. This creates an identifiability problem that is deeper than ordinary uncertainty in parameter estimation: the scientific question is whether competing molecular expla

---

Read More

Noncoding cancer-associated variants are frequently located in regulatory regions whose biological consequences cannot be inferred reliably from genomic position or statistical association alone. Establishing an effector gene requires evidence that a candidate variant alters regulatory function in an appropriate cellular context and that this alteration can be connected to a specific gene or downstream phenotype. This scoping review mapped experimental and computational strategies used between 2

---

Read More

Synthetic lethality has become an important strategy for exploiting selective vulnerabilities created by cancer-associated molecular alterations. Yet the therapeutic expression of a synthetic-lethal relationship is often less stable than a simple pairwise genetic model implies. Dependency can vary with cellular background, compensatory paralog activity, metabolic configuration, treatment exposure, and the experimental conditions used to measure fitness. This theoretical article develops an evide

---

Read More

Therapeutic enzymes are often engineered through molecular objectives that can be measured efficiently in vitro, including catalytic activity, substrate selectivity, folding stability, and expression yield. Yet therapeutic performance emerges only after these molecular properties interact with glycosylation, systemic persistence, receptor-mediated distribution, tissue access, intracellular trafficking, and host immune recognition. Optimizing a single measurable attribute can therefore improve on

---

Read More

Therapeutic epigenome editing creates an unusual temporal problem: the molecular editor may be present only briefly, whereas the regulatory state established during that exposure can persist long after the initiating intervention has disappeared. Durable repression after transient delivery has now been demonstrated in several experimental settings, yet persistence is not an intrinsic consequence of depositing an epigenetic mark. Regulatory outcomes vary with locus architecture, chromatin context

---

Read More

Persistent tumor cells that survive anticancer therapy can remain viable despite profound suppression of proliferation, yet survival during treatment and recovery after treatment withdrawal are biologically distinct events. This integrative review examines how metabolic state, enzyme regulation, proteome remodeling, nutrient use, and redox control may shape the transition from treatment persistence to renewed proliferative capacity. Evidence published from 2017 through 2026 was synthesized acros

---

Read More

Engineered enzyme selectivity is frequently judged by improved substrate preference or product distributions, yet the kinetic origin of those changes is often unresolved. Conformational dynamics offers a mechanistic explanation when mutations redistribute catalytically competent states, change interconversion rates, or alter access to competing reaction channels. This critical review distinguishes the measurable endpoints of substrate discrimination from assignments to binding, chemical conversi

---

Read More

A sequence variant can alter RNA processing, the amount of protein produced, its molecular properties, or a downstream cellular phenotype. These effects may coexist, yet measurements at different levels need not agree. Functional-genomic screens measure such endpoints as transcript inclusion, growth, or reporter activity, whereas quantitative proteomics measures sampled peptides and proteins under particular analytical conditions. This integrative methodological review examines how complementary

---

Read More

Engineered microbial pathways operate within cells whose metabolic resources, physiological states, and population compositions change during cultivation. A pathway that increases short-term product accumulation may simultaneously consume translation capacity, perturb precursor supply, or select for nonproducing variants. This conceptual synthesis asks when dynamic regulation can reconcile enzyme capacity, resource allocation, cellular burden, and sustained production, and when that expectation

---

Read More

Biochemical affinity is an incomplete descriptor of anticancer drug action when drug concentrations, target availability, and signaling states change over time. This critical review examines the conditions under which association and dissociation kinetics improve the interpretation of sustained pharmacological responses and the circumstances in which other processes can produce a similar phenotype. Evidence from biochemical measurements, living-cell engagement assays, covalent-inhibitor studies,

---

Read More

Programmable expression control can determine whether a gene-therapy product remains spatially selective, dose-appropriate and controllable after delivery. This critical translational review examines regulatory circuits as a distinct engineering layer, rather than treating vector targeting or initial transduction as sufficient evidence of controlled therapy. Peer-reviewed experimental studies and focused methodological literature published through 1 November 2026 were selected purposively to com

---

Read More

Cancer transcriptomes contain abundant alternative splice junctions, but the existence of an abnormal RNA does not establish an altered protein product, still less a therapeutically exploitable dependency. This integrative review follows evidence from splice-site choice and transcript fate through mass-spectrometric protein identification, isoform-specific function, and intervention. Genomic and RNA-based studies reveal recurrent splicing disruption, whereas proteogenomic analyses show that the

---

Read More